- Home
- ANIP vs NMZ Comparison
ANIP vs NMZ Comparison
Compare ANIP & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- NMZ
- Stock Information
- Founded
- ANIP 2001
- NMZ 2003
- Country
- ANIP United States
- NMZ United States
- Employees
- ANIP N/A
- NMZ N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- NMZ Finance/Investors Services
- Sector
- ANIP Health Care
- NMZ Finance
- Exchange
- ANIP Nasdaq
- NMZ Nasdaq
- Market Cap
- ANIP 1.2B
- NMZ 1.2B
- IPO Year
- ANIP N/A
- NMZ N/A
- Fundamental
- Price
- ANIP $68.02
- NMZ $10.91
- Analyst Decision
- ANIP Strong Buy
- NMZ
- Analyst Count
- ANIP 8
- NMZ 0
- Target Price
- ANIP $79.75
- NMZ N/A
- AVG Volume (30 Days)
- ANIP 361.8K
- NMZ 356.8K
- Earning Date
- ANIP 05-09-2025
- NMZ 01-01-0001
- Dividend Yield
- ANIP N/A
- NMZ 5.08%
- EPS Growth
- ANIP N/A
- NMZ N/A
- EPS
- ANIP N/A
- NMZ N/A
- Revenue
- ANIP $614,376,000.00
- NMZ N/A
- Revenue This Year
- ANIP $27.62
- NMZ N/A
- Revenue Next Year
- ANIP $7.71
- NMZ N/A
- P/E Ratio
- ANIP N/A
- NMZ N/A
- Revenue Growth
- ANIP 26.20
- NMZ N/A
- 52 Week Low
- ANIP $52.50
- NMZ $8.26
- 52 Week High
- ANIP $70.00
- NMZ $11.14
- Technical
- Relative Strength Index (RSI)
- ANIP 66.14
- NMZ 40.50
- Support Level
- ANIP $65.28
- NMZ $10.79
- Resistance Level
- ANIP $69.33
- NMZ $10.94
- Average True Range (ATR)
- ANIP 2.32
- NMZ 0.09
- MACD
- ANIP 0.29
- NMZ -0.02
- Stochastic Oscillator
- ANIP 83.54
- NMZ 35.29
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.